Conclusion by a subsidiary of NanoGroup S.A. of a funding agreement for the NanOX 4 Kidney project – a new generation of kidney perfusion fluid based on a synthetic oxygen carrier

Conclusion by a subsidiary of NanoGroup S.A. of a funding agreement for the NanOX 4 Kidney project – a new generation of kidney perfusion fluid based on a synthetic oxygen carrier
04.08.2025

Conclusion by a subsidiary of NanoGroup S.A. of a funding agreement for the NanOX 4 Kidney project – a new generation of kidney perfusion fluid based on a synthetic oxygen carrier

ESPI Report 26/2025
23.07.2025

ESPI Report 26/2025

Adoption by the Board of Directors of a resolution on the issue of series K shares as part of an increase in share capital within the limits of authorized capital
10.07.2025

Adoption by the Board of Directors of a resolution on the issue of series K shares as part of an increase in share capital within the limits of authorized capital

Correction No. 2 of the document related to the admission to trading on a regulated market operated by the Warsaw Stock Exchange S.A. of series M1, M2, M3, M4, M5, M6, M7 and L1 shares of NANOGROUP SPÓŁKA AKCYJNA (PLNNGRP00011).
03.07.2025

Correction No. 2 of the document related to the admission to trading on a regulated market operated by the Warsaw Stock Exchange S.A. of series M1, M2, M3, M4, M5, M6, M7 and L1 shares of NANOGROUP SPÓŁKA AKCYJNA (PLNNGRP00011).

List of shareholders holding at least 5% of the number of votes at the Annual General Meeting of NanoGroup S.A. on June 27, 2025 NANOGROUP SPÓŁKA AKCYJNA (PLNNGRP00011)
03.07.2025

List of shareholders holding at least 5% of the number of votes at the Annual General Meeting of NanoGroup S.A. on June 27, 2025 NANOGROUP SPÓŁKA AKCYJNA (PLNNGRP00011)

Resolution of the Supervisory Board of the Company under the business name NANOGROUP Spółka Akcyjna, a joint stock company with its registered office in Warsaw, Poland (hereinafter referred to as “the Company”) on the adoption of the Report of the Supervisory Board of the Company for the year 2024
27.06.2025

Resolution of the Supervisory Board of the Company under the business name NANOGROUP Spółka Akcyjna, a joint stock company with its registered office in Warsaw, Poland (hereinafter referred to as “the Company”) on the adoption of the Report of the Supervisory Board of the Company for the year 2024

pp-thumbnail